| Lipid Composition for APS-201 | Amount (µmol/vial) | Concentration (mg/vial) | Molar Ratio Percentage |
|---|---|---|---|
| L-alpha-phosphatidylserine | 1.50 | 1.21 | 100 |
| Lipid Composition for APS-202 | Amount (µmol/vial) | Amount (mg/vial) | Molar Ratio Percentage |
|---|---|---|---|
| L-alpha-phosphatidylserine | 1.35 | 1.09 | 90 |
| L-alpha-Phosphatidylcholine | 0.15 | 0.12 | 10 |
| Total | 1.50 µmol/vial | 1.21 mg/vial | 100 |
| Lipid Composition for APS-203 | Amount (µmol/vial) | Amount (mg/vial) | Molar Ratio Percentage |
|---|---|---|---|
| L-alpha-phosphatidylserine | 1.20 | 0.97 | 80 |
| L-alpha-Phosphatidylcholine | 0.30 | 0.23 | 20 |
| Total | 1.50 µmol/vial | 1.20 mg/vial | 100 |
| Lipid Composition for APS-204 | Amount (µmol/vial) | Amount (mg/vial) | Molar Ratio Percentage |
|---|---|---|---|
| L-alpha-phosphatidylserine | 1.05 | 0.85 | 70 |
| L-alpha-Phosphatidylcholine | 0.45 | 0.35 | 30 |
| Total | 1.50 µmol/vial | 1.20 mg/vial | 100 |
| Lipid Composition for APS-205 | Amount (µmol/vial) | Amount (mg/vial) | Molar Ratio Percentage |
|---|---|---|---|
| L-alpha-phosphatidylserine | 0.90 | 0.73 | 60 |
| L-alpha-Phosphatidylcholine | 0.60 | 0.46 | 40 |
| Total | 1.50 µmol/vial | 1.19 mg/vial | 100 |
| Lipid Composition for APS-206 | Amount (µmol/vial) | Amount (mg/vial) | Molar Ratio Percentage |
|---|---|---|---|
| L-alpha-phosphatidylserine | 0.75 | 0.60 | 50 |
| L-alpha-Phosphatidylcholine | 0.75 | 0.58 | 50 |
| Total | 1.50 µmol/vial | 1.18 mg/vial | 100 |
| Lipid Composition for APS-207 | Amount (µmol/vial) | Amount (mg/vial) | Molar Ratio Percentage |
|---|---|---|---|
| L-alpha-phosphatidylserine | 0.60 | 0.48 | 40 |
| L-alpha-Phosphatidylcholine | 0.90 | 0.69 | 60 |
| Total | 1.50 µmol/vial | 1.17 mg/vial | 100 |
| Lipid Composition for APS-208 | Amount (µmol/vial) | Amount (mg/vial) | Molar Ratio Percentage |
|---|---|---|---|
| L-alpha-phosphatidylserine | 0.45 | 0.36 | 30 |
| L-alpha-Phosphatidylcholine | 1.05 | 0.81 | 70 |
| Total | 1.50 µmol/vial | 1.17 mg/vial | 100 |
| Lipid Composition for APS-209 | Amount (µmol/vial) | Amount (mg/vial) | Molar Ratio Percentage |
|---|---|---|---|
| L-alpha-phosphatidylserine | 0.30 | 0.24 | 20 |
| L-alpha-Phosphatidylcholine | 1.20 | 0.92 | 80 |
| Total | 1.50 µmol/vial | 1.16 mg/vial | 100 |
| Lipid Composition for APS-210 | Amount (µmol/vial) | Amount (mg/vial) | Molar Ratio Percentage |
|---|---|---|---|
| L-alpha-phosphatidylserine | 0.15 | 0.12 | 10 |
| L-alpha-Phosphatidylcholine | 1.35 | 1.04 | 90 |
| Total | 1.50 µmol/vial | 1.16 mg/vial | 100 |
